BIOAGE LABS INC (BIOA) — insider trading
Health Care · NASDAQ
BIOAGE LABS INC (BIOA) has 39 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 39 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 7,861 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 4,065 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 4,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 4,290 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Open-market sale | 20,216 | $25.19 | $509.2K | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 7,861 | $4.38 | $34.4K | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 4,065 | $4.30 | $17.5K | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 4,000 | $8.39 | $33.6K | Form 4 |
| 2026-06-30 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 4,290 | $10.85 | $46.5K | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 14,198 | $0.00 | $0 | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 8,958 | $0.00 | $0 | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 7,261 | $0.00 | $0 | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion (derivative) | 9,301 | $0.00 | $0 | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Open-market sale | 42,350 | $25.21 | $1.07M | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 14,198 | $4.38 | $62.2K | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 8,958 | $4.30 | $38.5K | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 7,261 | $8.39 | $60.9K | Form 4 |
| 2026-06-29 | Barton Shane | Officer (Principal Accounting Officer) | Option exercise / conversion | 9,301 | $10.85 | $100.9K | Form 4 |
| 2026-06-10 | GARNIER JEAN PIERRE | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Davidson Michael H. | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-10 | ENRIGHT PATRICK G | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-10 | HEALY JAMES | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Hemrajani Rekha | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Pande Vijay Satyanand | Director | Grant / award / vesting (derivative) | 22,000 | $0.00 | $0 | Form 4 |
| 2026-04-23 | GOLDSTEIN DOV A MD | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 3,542 | $0.00 | $0 | Form 4 |
| 2026-04-23 | GOLDSTEIN DOV A MD | Officer (Chief Financial Officer) | Option exercise / conversion | 3,542 | $4.38 | $15.5K | Form 4 |
| 2026-04-01 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,383 | $0.00 | $0 | Form 4 |
| 2026-04-01 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 5,437 | $0.00 | $0 | Form 4 |
| 2026-04-01 | RUBIN PAUL D | Officer (Chief Medical Officer) | Open-market sale | 8,820 | $17.81 | $157.1K | Form 4 |
| 2026-04-01 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion | 3,383 | $6.57 | $22.2K | Form 4 |
| 2026-04-01 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion | 5,437 | $4.11 | $22.3K | Form 4 |
| 2026-03-02 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 2,000 | $0.00 | $0 | Form 4 |
| 2026-03-02 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 5,433 | $0.00 | $0 | Form 4 |
| 2026-03-02 | RUBIN PAUL D | Officer (Chief Medical Officer) | Open-market sale | 7,433 | $20.30 | $150.9K | Form 4 |
| 2026-03-02 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion | 2,000 | $6.57 | $13.1K | Form 4 |
| 2026-03-02 | RUBIN PAUL D | Officer (Chief Medical Officer) | Option exercise / conversion | 5,433 | $4.11 | $22.3K | Form 4 |
| 2026-03-01 | GOLDSTEIN DOV A MD | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 3,542 | $0.00 | $0 | Form 4 |
| 2026-03-01 | GOLDSTEIN DOV A MD | Officer (Chief Financial Officer) | Option exercise / conversion | 3,542 | $4.38 | $15.5K | Form 4 |
| 2026-02-17 | RUBIN PAUL D | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 110,000 | $0.00 | $0 | Form 4 |
Ask the chat about BIOA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: BIOAGE LABS INC (BIOA).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.